Ninaad Lasrado, PhD
@ninaadlasrado.bsky.social
Postdoc @BarouchLab/ @harvardmed/@BIDMChealth | Ph.D @unlincoln | Interested in mRNA therapeutics, mucosal immunity, and bioengineering vaccines for infectious diseases
#longcovid or PASC may be characterized by persistent activation of chronic inflammatory pathways, affecting millions of Americans. Our latest #clinical trial focuses on repurposing Abrocitinib to reduce symptoms in people with #LongCOVID. (1/2)
March 29, 2025 at 1:30 AM
#longcovid or PASC may be characterized by persistent activation of chronic inflammatory pathways, affecting millions of Americans. Our latest #clinical trial focuses on repurposing Abrocitinib to reduce symptoms in people with #LongCOVID. (1/2)
Are there any Long Covid groups here on Bluesky where one could distribute information on new LC clinical trials?
March 4, 2025 at 3:41 PM
Are there any Long Covid groups here on Bluesky where one could distribute information on new LC clinical trials?
Hello friends! Has anyone been able to produce stabilized FLsE of H5 Texas HA with any stabilizing mutations ? If so, what mutations did you use? Any help is much appreciated ! @goranbasic.bsky.social @scottehensley.bsky.social
November 17, 2024 at 12:39 PM
Hello friends! Has anyone been able to produce stabilized FLsE of H5 Texas HA with any stabilizing mutations ? If so, what mutations did you use? Any help is much appreciated ! @goranbasic.bsky.social @scottehensley.bsky.social
Our recent data on Neutralization escape of BA.2.86, EG.5.1, and FL.1.5.1 SARS-cov-2 variants is out now!
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variant BA.2.86 has over 30 mutations in spike compared with BA.2 and XBB.1.5, which …
www.sciencedirect.com
October 22, 2023 at 1:16 AM
Our recent data on Neutralization escape of BA.2.86, EG.5.1, and FL.1.5.1 SARS-cov-2 variants is out now!
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Reposted by Ninaad Lasrado, PhD
First few day on bsky - I am Nick a MD/PhD working on developing computational frameworks to bring TCR sequencing into the clinic at Omniscope. My free time is mostly spent running after my daughter and writing open-source R packages for single-cell sequencing. Excited to meet new people here!
September 10, 2023 at 10:51 PM
First few day on bsky - I am Nick a MD/PhD working on developing computational frameworks to bring TCR sequencing into the clinic at Omniscope. My free time is mostly spent running after my daughter and writing open-source R packages for single-cell sequencing. Excited to meet new people here!
SARS-CoV-2 is rapidly evolving with the emergence of immune evasive variants. Where are we at now with the durability of vaccines, natural infection, and hybrid immunity? Check out our new Viewpoint on SARS-CoV-2 hybrid immunity!
https://t.co/96pvLwUFGh
https://t.co/96pvLwUFGh
t.co
August 19, 2023 at 10:08 PM
SARS-CoV-2 is rapidly evolving with the emergence of immune evasive variants. Where are we at now with the durability of vaccines, natural infection, and hybrid immunity? Check out our new Viewpoint on SARS-CoV-2 hybrid immunity!
https://t.co/96pvLwUFGh
https://t.co/96pvLwUFGh